574 related articles for article (PubMed ID: 28058026)
1. Economic burden of irritable bowel syndrome in China.
Zhang F; Xiang W; Li CY; Li SC
World J Gastroenterol; 2016 Dec; 22(47):10450-10460. PubMed ID: 28058026
[TBL] [Abstract][Full Text] [Related]
2. Annual Costs of Care for Pediatric Irritable Bowel Syndrome, Functional Abdominal Pain, and Functional Abdominal Pain Syndrome.
Hoekman DR; Rutten JM; Vlieger AM; Benninga MA; Dijkgraaf MG
J Pediatr; 2015 Nov; 167(5):1103-8.e2. PubMed ID: 26329806
[TBL] [Abstract][Full Text] [Related]
3. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
[TBL] [Abstract][Full Text] [Related]
4. Economic burden of moderate to severe irritable bowel syndrome with constipation in six European countries.
Tack J; Stanghellini V; Mearin F; Yiannakou Y; Layer P; Coffin B; Simren M; Mackinnon J; Wiseman G; Marciniak A;
BMC Gastroenterol; 2019 May; 19(1):69. PubMed ID: 31064345
[TBL] [Abstract][Full Text] [Related]
5. Economic Burden of Irritable Bowel Syndrome with Diarrhea: Retrospective Analysis of a U.S. Commercially Insured Population.
Buono JL; Mathur K; Averitt AJ; Andrae DA
J Manag Care Spec Pharm; 2017 Apr; 23(4):453-460. PubMed ID: 28345443
[TBL] [Abstract][Full Text] [Related]
6. A systematic review of the economic and humanistic burden of illness in irritable bowel syndrome and chronic constipation.
Nellesen D; Yee K; Chawla A; Lewis BE; Carson RT
J Manag Care Pharm; 2013; 19(9):755-64. PubMed ID: 24156644
[TBL] [Abstract][Full Text] [Related]
7. Health-related quality of life, work productivity, and indirect costs among patients with irritable bowel syndrome with diarrhea.
Buono JL; Carson RT; Flores NM
Health Qual Life Outcomes; 2017 Feb; 15(1):35. PubMed ID: 28196491
[TBL] [Abstract][Full Text] [Related]
8. Total costs of IBS: employer and managed care perspective.
Cash B; Sullivan S; Barghout V
Am J Manag Care; 2005 Apr; 11(1 Suppl):S7-16. PubMed ID: 15926759
[TBL] [Abstract][Full Text] [Related]
9. Review article: the economic impact of the irritable bowel syndrome.
Canavan C; West J; Card T
Aliment Pharmacol Ther; 2014 Nov; 40(9):1023-34. PubMed ID: 25199904
[TBL] [Abstract][Full Text] [Related]
10. Systematic review: the economic impact of irritable bowel syndrome.
Inadomi JM; Fennerty MB; Bjorkman D
Aliment Pharmacol Ther; 2003 Oct; 18(7):671-82. PubMed ID: 14510740
[TBL] [Abstract][Full Text] [Related]
11. The economic consequences of irritable bowel syndrome: a US employer perspective.
Leong SA; Barghout V; Birnbaum HG; Thibeault CE; Ben-Hamadi R; Frech F; Ofman JJ
Arch Intern Med; 2003 Apr; 163(8):929-35. PubMed ID: 12719202
[TBL] [Abstract][Full Text] [Related]
12. Economic cost of Guillain-Barré syndrome in the United States.
Frenzen PD
Neurology; 2008 Jul; 71(1):21-7. PubMed ID: 18591502
[TBL] [Abstract][Full Text] [Related]
13. Costs of irritable bowel syndrome in European countries with universal healthcare coverage: a meta-analysis.
Flacco ME; Manzoli L; De Giorgio R; Gasbarrini A; Cicchetti A; Bravi F; Altini M; Caio GP; Ursini F
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2986-3000. PubMed ID: 31002149
[TBL] [Abstract][Full Text] [Related]
14. Comparison of medical costs generated by IBS patients in primary and secondary care in the Netherlands.
Flik CE; Laan W; Smout AJ; Weusten BL; de Wit NJ
BMC Gastroenterol; 2015 Nov; 15():168. PubMed ID: 26612205
[TBL] [Abstract][Full Text] [Related]
15. Irritable bowel syndrome in France: quality of life, medical management, and costs: the Encoli study.
Brun-Strang C; Dapoigny M; Lafuma A; Wainsten JP; Fagnani F
Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1097-103. PubMed ID: 17998835
[TBL] [Abstract][Full Text] [Related]
16. How does comorbidity affect cost of health care in patients with irritable bowel syndrome? A cohort study in general practice.
Johansson PA; Farup PG; Bracco A; Vandvik PO
BMC Gastroenterol; 2010 Mar; 10():31. PubMed ID: 20233451
[TBL] [Abstract][Full Text] [Related]
17. Economic burden of schizophrenia: empirical analyses from a survey in Thailand.
Phanthunane P; Whiteford H; Vos T; Bertram M
J Ment Health Policy Econ; 2012 Mar; 15(1):25-32. PubMed ID: 22611090
[TBL] [Abstract][Full Text] [Related]
18. Costs of irritable bowel syndrome in the UK and US.
Maxion-Bergemann S; Thielecke F; Abel F; Bergemann R
Pharmacoeconomics; 2006; 24(1):21-37. PubMed ID: 16445300
[TBL] [Abstract][Full Text] [Related]
19. [Irritable bowel syndrome: epidemiology/economic burden].
Dapoigny M
Gastroenterol Clin Biol; 2009 Feb; 33 Suppl 1():S3-8. PubMed ID: 19303536
[TBL] [Abstract][Full Text] [Related]
20. Burden of rheumatoid arthritis from a societal perspective: A prevalence-based study on cost of this illness for patients in China.
Hu H; Luan L; Yang K; Li SC
Int J Rheum Dis; 2018 Aug; 21(8):1572-1580. PubMed ID: 28211251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
